Items tagged with Drug-resistant TB
Webinar: An update on the use of bedaquiline and delamanid in children with MDR-TB (post)
The Sentinel Project will hold a webinar on June 7th, from 09:00-10:00 EDT (15:00-16:00 CET).
Treatment for drug-resistant TB now available in the Philippines (post)
The fight against drug-resistant tuberculosis in the country is set to get a boost with a new treatment now made available locally.
Antibiotic resistance is “already here” and pipeline is dry, UK health minister tells UN (post)
NEW YORK, June 8, 2016 — An estimated one million people may already die each year because they are resistant to all known antibiotics, and the number could reach 10 million per year and devastate the world economy by 2050 unless key steps are taken, experts from the United Kingdom and South Africa told a press briefing on antimicrobial resistance at United Nations headquarters today.
India: Assam first state to launch miracle TB medicine (post)
GUWAHATI, June 6 - Assam has become the first state of the country to launch the miracle drug bedaquiline – the first new medicine for TB in more than 40 years – for treatment of drug-resistant TB.
Frequently asked questions on shorter MDR-TB regimen (post)
The World Health Organization (WHO)'s Global TB Program has released Frequently asked questions about the implementation of the new WHO recommendation on the use of the shorter MDR-TB regimen under programmatic conditions.
What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis (post)
Abstract
Bedaquiline: A new hope to MDR-TB patients in the Philippines (post)
The first new drug to treat tuberculosis in more than 40 years, Bedaquiline is helping patients fight multidrug-resistant tuberculosis (MDR-TB) through its donation program – a public-private partnership between United States Agency for International Development (USAID) and Janssen Therapeutics of Johnson & Johnson.
WHO recommendations on shorter MDR-TB treatment (post)
The recent release by WHO of new recommendations aimed at speeding up tuberculosis drug susceptibility testing using a rapid molecular MTBDRsl test and use of shorter multidrug-resistant tuberculosis (MDR-TB) treatment regimens is a long-awaited development. Although the new recommendations are welcomed, there are concerns about whether the shorter MDR-TB treatment regimen is likely to be effective in all geographical settings.
Research hones in on new TB drugs (post)
University of Queensland (UQ) scientists are honing in on drug-resistant tuberculosis (TB), in a project which could lead to new antibiotics.
Page 30 of 117 · Total posts: 0
←First 29 30 31 Last→